Enanta Pharmaceuticals

ENTANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$352.709 M

$12.11 -0.74%

Close of 21 Sept 2026

Revenue

$65.3M

#2652 by revenue

Earnings

-$81.9M

Loss-making

Shares outstanding

29,125,402

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#226Cypherpunk TechnologiesCYPH$366.4M
#227Rocket PharmaceuticalsRCKT$359.0M
#228Enanta PharmaceuticalsENTA$352.7M
#229EvommuneEVMN$343.0M
#230Perspective TherapeuticsCATX$339.0M

What if Enanta Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$1,039,438

Per share 85,833× higher

Bitcoin $1.72T

$59,048.24

Per share 4,876× higher

Nvidia $5.48T

$188,147.03

Per share 15,537× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Enanta Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.